Filing metadata

Accession number
0001493152-24-034366
Form type
Form 3
Filer
Telomir Pharmaceuticals, Inc.
CIK
CIK 1971532
Filed
Aug 29, 2024
Reporting period
Jun 18, 2024
Description
Initial ownership

Explore SEC Filings Hub